LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Return
10.14%
This Quarter Return
+7.22%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$437M
AUM Growth
+$28.3M
(+6.9%)
Cap. Flow
+$4.82M
Cap. Flow
% of AUM
1.1%
Top 10 Holdings %
Top 10 Hldgs %
57.23%
Holding
1,992
New
167
Increased
801
Reduced
159
Closed
72
Top Buys
| 1 |
Oaktree Specialty Lending
OCSL
|
$11.7M |
| 2 |
Caesars Entertainment
CZR
|
$3.98M |
| 3 |
Apple
AAPL
|
$2.14M |
| 4 |
IBM
IBM
|
$940K |
| 5 |
NXU.U
Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi
NXU.U
|
$600K |
Top Sells
| 1 |
OCSI
Oaktree Strategic Income Corporation
OCSI
|
$11M |
| 2 |
Direxion Daily S&P 500 Bear 1X Shares
SPDN
|
$6.01M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$1.33M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$916K |
| 5 |
Tesla
TSLA
|
$702K |
Sector Composition
| 1 | Financials | 16.11% |
| 2 | Technology | 12.51% |
| 3 | Consumer Discretionary | 4.79% |
| 4 | Healthcare | 3.69% |
| 5 | Communication Services | 3.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Costco
COST
$427B
| $131K | 0.03% |
371
+33
| +10% | +$11.7K |
|
227
Zebra Technologies
ZBRA
$16B
| $129K | 0.03% |
266
+12
| +5% | +$5.82K |
|
228
Takeda Pharmaceutical
TAK
$48.6B
| $128K | 0.03% |
7,016
+586
| +9% | +$10.7K |
|
229
IQVIA
IQV
$31.9B
| $127K | 0.03% |
657
+35
| +6% | +$6.77K |
|
230
Cigna
CI
$81.5B
| $126K | 0.03% |
521
+61
| +13% | +$14.8K |
|
231
Morgan Stanley
MS
$236B
| $126K | 0.03% |
1,626
+207
| +15% | +$16K |
|
232
Twilio
TWLO
$16.7B
| $126K | 0.03% |
370
+35
| +10% | +$11.9K |
|
233
TG Therapeutics
TGTX
$5.11B
| $125K | 0.03% |
2,600
+1,100
| +73% | +$52.9K |
|
234
Illinois Tool Works
ITW
$77.6B
| $123K | 0.03% |
554
+14
| +3% | +$3.11K |
|
235
Otis Worldwide
OTIS
$34.1B
| $123K | 0.03% |
1,793
+8
| +0.4% | +$549 |
|
236
Ferrari
RACE
$87.1B
| $123K | 0.03% |
590
+38
| +7% | +$7.92K |
|
237
TJX Companies
TJX
$155B
| $121K | 0.03% |
1,822
+87
| +5% | +$5.78K |
|
|
RTP.U
238
DELISTED
Reinvent Technology Partners Units, each consisting of one Class A ordinary share and one-fourth of
RTP.U
| $121K | 0.03% |
11,271
-1,923
| -15% | -$20.6K |
|
239
Prologis
PLD
$105B
| $120K | 0.03% |
1,129
+92
| +9% | +$9.78K |
|
240
Stryker
SYK
$150B
| $120K | 0.03% |
492
+33
| +7% | +$8.05K |
|
241
Linde
LIN
$220B
| $119K | 0.03% |
424
+158
| +59% | +$44.3K |
|
242
Hologic
HOLX
$14.8B
| $118K | 0.03% |
1,592
+41
| +3% | +$3.04K |
|
243
Ocular Therapeutix
OCUL
$2.37B
| $118K | 0.03% |
7,200
+3,452
| +92% | +$56.6K |
|
244
Nomura Holdings
NMR
$21.1B
| $117K | 0.03% |
21,789
+84
| +0.4% | +$451 |
|
245
SK Telecom
SKM
$8.38B
| $117K | 0.03% |
2,618
| – | – |
|
246
Take-Two Interactive
TTWO
$44.2B
| $116K | 0.03% |
655
+30
| +5% | +$5.31K |
|
247
BHP
BHP
$138B
| $115K | 0.03% |
1,856
+154
| +9% | +$9.54K |
|
248
Republic Services
RSG
$71.7B
| $113K | 0.03% |
1,140
+7
| +0.6% | +$694 |
|
249
Vanguard S&P 500 Growth ETF
VOOG
$19.3B
| $113K | 0.03% |
481
| – | – |
|
250
Vertex Pharmaceuticals
VRTX
$102B
| $112K | 0.03% |
523
+11
| +2% | +$2.36K |
|